Join to View Full Profile
1300 E Marshall StRichmond, VA 23298
Phone+1 804-628-5054
Fax+1 804-828-7825
Dr. Clark is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
Virginia Commonwealth University Health SystemResidency, Internal Medicine, 2004 - 2007
Virginia Commonwealth University School of MedicineClass of 2004
Certifications & Licensure
VA State Medical License 2004 - 2026
TN State Medical License 2007 - 2010
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Cerner Millennium Powerchart, Cerner Millennium FirstNet, Cerner Millennium ProFile, Health Sentry, Healthe Exchange, Cerner Healthe Record, IQHealth and P2 Sentinel (Powered by Sensage), Cerner Corporation, 2013
- CMS Meaningful Use Stage 1 Certification Cerner Millennium Powerchart, Cerner Millennium FirstNet, Cerner Millennium ProFile, Health Sentry, Healthe Exchange, Cerner Healthe Record, IQHealth and P2 Sentinel (Powered by Sensage), Cerner Corporation, 2013
- CMS Meaningful Use Stage 1 Certification Cerner Millennium Powerchart, Cerner Millennium FirstNet, Cerner Millennium ProFile, Health Sentry, Healthe Exchange, Cerner Healthe Record, IQHealth and P2 Sentinel (Powered by Sensage), Cerner Corporation, 2013
Clinical Trials
- Biomarkers in Predicting Response in Patients With Graft-Versus-Host Disease Undergoing Extracorporeal Photophoresis Start of enrollment: 2011 Jul 01
- Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma Start of enrollment: 2023 May 09
Roles: Contact, Principal Investigator
- Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics Start of enrollment: 2024 Feb 01
Roles: Contact
Publications & Presentations
PubMed
- 1 citationsReal-world outcomes and toxicities of CAR-T in relapsed/refractory follicular lymphoma: a multicenter cohort study.John Sharp, Paolo Strati, Subodh Bhatta, Jennifer J Huang, Colin Thomas
Blood Advances. 2026-06-09 - Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 study.Jakob Wirbel, Wael Saber, Michael J Martens, Jonathan U Peled, Tessa M Andermann
Biorxiv. 2026-02-19 - 1 citationsSafety and efficacy of BCMA-directed chimeric antigen receptor T-cell therapy for the treatment of plasma cell leukemia.Gliceida M Galarza Fortuna, Lauren Peres, Elena Nazarenko, Andre De Menezes Silva Corraes, Vanna N Hovanky
Blood Advances. 2025-12-09
Journal Articles
- Treatment of Acute Fibrinous Organizing Pneumonia Following Hematopoietic Cell Transplantation with EtanerceptK Miller, W B Clark, J M McCarty, A A Toor, H M Chung, Nature
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
